State Street Increases Stake in Avadel Pharmaceuticals by 2.34%
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Dec 12 2025
0mins
Source: Globenewswire
- Stake Increase: State Street Global Advisors and its affiliates increased their stake in Avadel Pharmaceuticals plc to 2.34% as of December 11, 2025, indicating strong confidence in the company's prospects.
- Transaction Details: The transaction involved the purchase of 700 shares and the sale of 900 shares, all at a price of $21.39 per share, reflecting a stable market expectation for Avadel.
- Market Impact: The increase in State Street's stake may enhance Avadel's market recognition, attracting more investor interest and potentially boosting its stock performance.
- Strategic Significance: By increasing its ownership, State Street not only strengthens its control over Avadel but also positions itself to exert greater influence in future shareholder decisions, further driving the company's strategic development.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
